SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Trading Update

17 Sep 2021 07:00

RNS Number : 0789M
Accsys Technologies PLC
17 September 2021
 

AIM: AXS

Euronext Amsterdam: AXS

 

17 September 2021

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Trading Update

 

Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create high performance, sustainable wood building products, today announces an unaudited trading update for the first five months of the 2022 financial year from 1 April 2021 to 31 August 2021 ("the period"), ahead of its Annual General Meeting to be held at 2.30pm (UK time) today.

Trading for 5 months to 31 August 2021

· Strong sales and revenue growth compared to the same period one year ago, which was more severely impacted by COVID-19 ('prior year'):

o Continued strong demand for both Accoya® wood and Tricoya® wood elements.

o 31% increase in Accoya® revenue to approximately €40m (a 22% increase compared to the same period two years ago1). This includes a 10% increase in revenue for Tricoya® customers.

o 18% increase in Accoya® sales volumes to approximately 24,664 m3 (an 8% increase compared to the same period two years ago1).

· These results and trading in the period reflect the following trends:

o Higher average selling prices for Accoya®, driven by sales price increases in the 2021 financial year and in the 2022 financial year to date, which reflect continuing strong demand and raw material costs in the period.

o Inventory levels of raw wood have remained low in the period due to industry supply chain challenges but are expected to improve in the remainder of the financial year.

o A planned maintenance stop in the period was moved to later in 2021.

· The integration of the Accoya® Color assets we purchased in the UK this year is progressing well, and we produced our first batch of Accoya® Color at our new site in the period.

· Net cash of approximately €8.3m compared to net debt of €12.2m as at 31 March 2021, reflecting the proceeds of the equity capital raise completed in May largely offset by investment in additional production capacity in Hull and Arnhem.

Tricoya® UK plant construction (Hull)

· Progress at Hull continues in line with the recent Accsys update published on 21 August 2021.

· Various workstreams, including mechanical, electrical, and civil works, are underway as we work towards having the plant commercially operational by July 2022.

Accoya® The Netherlands plant expansion (Arnhem)

· Good progress in the planned extension of the existing Accoya® plant at Arnhem, the Netherlands. Project remains on track to be operational by the end of Q1 calendar year 2022.

· The installation of a fourth reactor will bring an additional 20,000m3 of capacity and increase the annual production capacity of the plant by 33% to 80,000m3 of Accoya®.

Accoya® USA plant joint venture

· Good progress has been made on the US JV with Eastman Chemical Corporation ahead of making the final investment decision to build an Accoya® plant with an initial 40,000m3 capacity at Kingsport, Tennessee and replicate our existing Accoya® technology at Arnhem.

· The front-end engineering and design ('FEED') of the plant is complete.

· Major agreements between the JV parties in relation to raw materials supply, support services, land & utilities are well advanced and are expected to be entered into on completion of the financing work stream.

· The project's debt-specific financing workstream is continuing and we expect to finalise terms in the coming months in line with our anticipated returns.

· The JV parties continue to work towards the plant being constructed by mid-2023 with the work completed to date confirming the significant opportunity for the JV.

Rob Harris, Accsys CEO, said:

"Accsys has made a strong start to the 2022 financial year. Our established Accoya® business has delivered double digit volume and revenue growth. This reflects continued strong customer demand, our price increases, product mix, and lapping the initial more severe effects of COVID-19 last year.

During the last five months we have continued to make good progress with the construction of a fourth reactor in Arnhem, advanced our US JV with Eastman and whilst we experienced some previously communicated challenges with the construction of our Hull Tricoya® facility, we are working through these and expect to have the plant commercially operational by July 2022. 

Looking ahead, we remain confident in delivering on full year expectations and underpinned by the clear market opportunities for our high-performance wood products, we continue to progress towards our ambitious 2025 fivefold increase in production target."

Notes:

1. A further comparison has been given against the same period two years ago which was pre-pandemic.

Ends

For further information, please contact:

Accsys Technologies PLCSarah Ogilvie, Investor Relations

ir@accsysplc.com

Numis Securities (London)Oliver Hardy (NOMAD), Ben Stoop

+44 (0) 20 7260 1000

Investec Bank plc (London)Carlton Nelson, Alex Wright

ABN Amro (Amsterdam)Richard van Etten, Dennis van Helmond

+44 (0) 20 7597 5970

+31 20 344 2000

FTI Consulting (UK)Matthew O'Keeffe, Alex Le May

+44 (0) 20 3727 1340 

Off the Grid (The Netherlands)Frank Neervoort, Yvonne Derske

+31 681 734 236

 

Notes to editors:

 

Accsys (Accsys Technologies PLC) is a fast-growing business with a purpose: changing wood to change the world. The company combines chemistry, technology and ingenuity to make Accoya® wood and Tricoya® wood elements: high performance wood products that are extremely durable and stable, opening new opportunities for the built environment and giving the world a choice to build sustainably. Accsys transforms fast-growing, certified sustainable wood into building materials with an up to 50-year warranty, locking carbon stored in the wood into useful products for decades, with performance characteristics that match or better those of non-renewable, resource-depleting and polluting alternatives. Accsys is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Visit www.accsysplc.com

Accoya® solid wood is sustainable, durable, and stable with exceptional performance, finish and sustainability. Accsys' proprietary acetylation process makes the wood more dimensionally stable and because it is no longer easily digestible, extremely durable. It is one of very few building materials to be Cradle to Cradle Certified™ at the Gold level, with a Platinum rating for Material Health, confirming that no harmful or toxic additives or chemicals are present to leach out into the environment. Primary applications for Accoya® wood include windows, doors, cladding and decking, where the combination of performance and sustainability benefits compete favorably against hardwoods, plastics, metals and concrete. Visit www.accoya.com 

Tricoya® acetylated wood elements are produced for use in the fabrication of panel products such as medium density fibreboard (MDF). Panel products made with Tricoya® wood elements are truly durable and stable enough for use outdoors and in wet environments, unlocking new possibilities for design and construction. They have been lauded as the first major innovation in the wood composites industry in more than 30 years and bring the flexibility of traditional panel products and sustainability benefits of wood to a whole new range of applications. Visit www.tricoya.com 

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. 'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFMEFMEFSESU
Date   Source Headline
25th May 20222:46 pmRNSResults of Equity Issue
25th May 20227:00 amRNSEquity Raise and Trading Update
4th Mar 20227:01 amRNSTrading Update
4th Mar 20227:00 amRNSFinal investment decision - Accoya® USA JV
27th Jan 20222:35 pmRNSAccsys Employee Share Participation Plan
24th Jan 20224:08 pmRNSNotifiable Interest – De Engh B.V.
30th Nov 20213:51 pmRNSNotifiable Interest – De Engh
23rd Nov 20217:00 amRNSInterim Results for six months ended 30 Sept 2021
8th Nov 20217:00 amRNSHull Tricoya plant funding update
5th Oct 20217:00 amRNSRefinancing of Group debt facilities
29th Sep 20218:00 amEQSEdison Investment Research Limited: Accsys Technologies (AXS): Building on strong foundations
24th Sep 20219:57 amRNSIssuance of Shares and Total Voting Rights
17th Sep 20214:17 pmRNSResult of AGM
17th Sep 20217:00 amRNSTrading Update
23rd Aug 20217:00 amRNSTricoya® plant construction update
12th Aug 20214:22 pmRNSDirectors’ Interests
4th Aug 202111:45 amRNSEmployee Benefit Trust and Directors’ Interests
29th Jul 20213:48 pmRNSIssuance of Shares and Total Voting Rights
29th Jul 20217:00 amRNSPurchase of assets for Accoya® Color production
27th Jul 20213:30 pmRNS2021 Annual Report and Notice of AGM
20th Jul 20213:58 pmRNSIssuance of Shares and Total Voting Rights
23rd Jun 20214:23 pmRNSDirector Interests and LTIP awards
22nd Jun 20214:21 pmRNSIssuance of Shares and Directors Interests
22nd Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21
8th Jun 20215:41 pmRNSNotifiable Interest - De Engh
7th Jun 20217:00 amRNSTricoya® plant construction update
3rd Jun 202111:51 amRNSNotifiable Interest - Teslin
2nd Jun 20219:05 amRNSNotifiable Interest - BGF Investment Management
25th May 202111:26 amRNSSuccessful Results of General Meeting and TVR
24th May 20214:05 pmRNSResult of Open Offer
6th May 202110:06 amRNSCircular and Notice of General Meeting
6th May 20217:00 amRNSResult of Placing
5th May 20214:37 pmRNSEquity Raise
16th Apr 20217:00 amRNSTrading Update - Year Ending March 2021
26th Mar 202112:44 pmRNSIssue of Equity
26th Feb 20214:22 pmRNSTotal Voting Rights
15th Feb 202111:00 amRNSAccsys Employee Share Participation Plan
31st Dec 202011:15 amRNSHome Member State
30th Nov 20205:31 pmRNSNotifiable Interest - Teslin Participaties
30th Nov 20207:01 amRNSAccsys publishes new ESG & Sustainability Report
30th Nov 20207:00 amRNSInterim Results for six months ended 30 Sept 2020
5th Nov 202011:00 amRNSProgress on Hull Tricoya Construction
18th Sep 202010:30 amRNSResult of AGM
18th Sep 20207:00 amRNSAGM Statement
18th Aug 20201:39 pmRNSNotice of AGM
12th Aug 20207:00 amRNSJoint Venture with Eastman Chemical Company
22nd Jul 20204:44 pmRNSNotifiable Interest - De Engh B.V.
21st Jul 20207:00 amRNSBoard Appointment of Alexander Wessels
15th Jul 20205:59 pmRNSDirector Interests and LTIP Awards
30th Jun 20209:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.